Recent Headlines
Pennington Biomedical Celebrates Employees for Service Milestones
Fourteen employees recognized for 20 years or more of service at Pennington Biomedical. - December 23, 2024 - Pennington Biomedical Research Center
Pennington Biomedical Conducts Study to Test Efficacy of Diabetes Medication for Cancer-Related Weight Loss
Dr. Justin Brown of Pennington Biomedical invites patients with lung or gastrointestinal cancers to participate in National Cancer Institute-funded trial. - December 23, 2024 - Pennington Biomedical Research Center
Impact of Government Assistance, Housing, and Employment on Postpartum Maternal Health Across Income and Race
Stressful periods such as COVID-19, hurricanes or infant formula shortages negatively impact racial groups differently. - December 13, 2024 - Pennington Biomedical Research Center
EBM Technologies and OmniPACS Partner to Transform Medical Imaging for Small to Medium Healthcare Providers in the US
EBM Technologies and OmniPACS are partnering to create accessible, AI-powered imaging solutions for U.S. healthcare providers. A pivotal meeting at MoMA inspired their creative vision for addressing challenges in medical imaging, blending EBM’s expertise with OmniPACS’s scalable platform. The partnership will debut innovations at RSNA 2024, focusing on solutions for small to medium healthcare facilities. - December 08, 2024 - OmniPACS Health Technologies LLC
The Role of Digital Technology in Diabetes Prevention and Management
Scientists at Pennington Biomedical Research Center, along with a colleague from Peking University People’s Hospital in China, have been leading a special collection and published an editorial in Frontiers in Endocrinology, emphasizing the transformative role digital health technologies play... - December 07, 2024 - Pennington Biomedical Research Center
Metabolic and Bariatric Surgery Safe and Effective for Patients with Severe Obesity
A multicenter examination of data demonstrates that for patients with a body mass index at or above 70 kg/m2 metabolic and bariatric surgery is a potent intervention. - December 07, 2024 - Pennington Biomedical Research Center
Dr. Stephanie Waldrop Joins Pennington Biomedical Research Center
New at Pennington Biomedical: Get to Know Dr. Stephanie Waldrop, assistant professor in Clinical Sciences - December 06, 2024 - Pennington Biomedical Research Center
Yael Freimann Named to NSBA Leadership Council
Yael Freimann of TI Verbatim Consulting (TIVC), was recently named to the National Small Business Association (NSBA) Leadership Council. NSBA is the nation’s oldest small-business advocacy organization, and operates on a staunchly nonpartisan basis. - December 02, 2024 - TI Verbatim Consulting
Harmonious Workplaces Announces New Cartoon Book: “Shermie the HR Hermit Crab”
Harmonious Workplaces has released “Shermie the HR Hermit Crab,” an 88-page cartoon book that tackles common workplace challenges with humor. Available on Amazon, this delightful book is ideal for HR professionals, managers, business executives, and anyone navigating the dynamics of modern workplaces. The book brings humor and heart to relatable scenarios. All ten comic strips end with a thoughtful lesson, making it both entertaining and insightful. - December 01, 2024 - Harmonious Workplaces
Pennington Biomedical Researchers Share Tips for the Holiday Season
From breakfast to holiday desserts, there are numerous ways to introduce small, manageable changes to your celebration. - November 20, 2024 - Pennington Biomedical Research Center
Let’s Win Pancreatic Cancer Selects TrialX to Launch Its First AI-Powered Global Clinical Trial Finder
Let’s Win Pancreatic Cancer, a go-to resource that guides patients and caregivers with vital information for better outcomes, launches a new global AI-based clinical trial finder - powered by TrialX - that aims to increase accessibility of clinical trial information for patients and families affected by pancreatic cancer. - November 19, 2024 - TrialX
Borderless Renewables Re-Emerges with Key Insights Into Decarbonised Electrification Policy Frameworks
After a period of focused scientific research, Borderless Renewables is re-emerging with pivotal insights into the policy frameworks essential for advancing decarbonised electrification. The global energy landscape is witnessing a rapid transformation, marked by the economic value of the... - November 07, 2024 - BorderlessRenewables
Rare Disease Foundation on the Road to Gene Therapy Brings Families to Fort Lauderdale from Around the World, November 15-17
The FOXG1 Research Foundation, the parent-led organization that is radically transforming the rare disease drug development landscape, is hosting an international conference in Fort Lauderdale from November 15-17, bringing families from across the globe together to learn about gene therapy advancements for FOXG1 syndrome. A highlight includes a presentation by 20-year-old Abraham Weitzman, who, though non-speaking, shares his lived experience using an innovative communication device. - November 04, 2024 - FOXG1 Research Foundation
GlycoMira Therapeutics Receives Key Patent for First-in-Class Oncology Therapeutic
Key patent covering GlycoMira's lead compound GM-1111 adds to the Company's already strong IP portfolio. - November 04, 2024 - GlycoMira Therapeutics, Inc.
Pennington Biomedical to be on Display at ObesityWeek 2024 in San Antonio
ObesityWeek is home to the latest developments in evidence-based obesity science. - November 02, 2024 - Pennington Biomedical Research Center
Minor Use Foundation Awarded $2M Grant from Assisting Specialty Crop Exports Initiative
Foundation to Support ASCE Project “Increasing Data Generation for Codex and Harmonized MRL Setting” - October 28, 2024 - Minor Use Foundation, Inc.
Zubaidah Nor Hanipah Joins Pennington Biomedical Research Center and the Metamor Institute
Get to Know Dr. Zubaidah "Zuby" Nor Hanipah, professor-research in clinical metabolic surgery. - October 26, 2024 - Pennington Biomedical Research Center
Pennington Biomedical's EAT2 Study to Explore Unknown Effects of Weight Fluctuations
The EAT2 study is recruiting participants now, and participants will be randomly assigned to the two groups - a control group that is weight stable and group with a diet that promotes weight gain. Both groups will participate in a dietary intervention program for 8 weeks, but those in the weight gain group will also be provided with an eight-week weight loss treatment following the dietary intervention. - October 26, 2024 - Pennington Biomedical Research Center
ClinTrial Research (CTR) Welcomes Wendy Tomlinson as the Company’s Chief Operating Officer
ClinTrial Research (CTR), proudly welcomes Wendy Tomlinson as the company’s Chief Operating Officer. Tomlinson will oversee activities related to clinical operations, project management, project delivery, and portfolio management. “I am excited for this new chapter and to have the... - October 07, 2024 - ClinTrial Research
Pennington Biomedical Partners on Army-Wide Health and Nutrition Study
Pennington Biomedical’s Center for Military Performance and Resilience and the U.S. Army Research Institute of Environmental Medicine collaborate on study; Louisiana’s Fort Johnson is first installation visit for study. - October 06, 2024 - Pennington Biomedical Research Center
Award-Winning Cleantech Startup Joins Cummings Properties' Woburn, MA Innovation Cluster
Active Surfaces, an early-stage solar technology company, expanded from Greentown Labs' cleantech incubator in Somerville, MA to a dedicated R&D facility in Cummings Properties' Woburn, MA innovation cluster. - October 05, 2024 - Cummings Properties
BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter for BUHLMANN fCAL® turbo and fPELA® turbo Assays
BÜHLMANN Laboratories AG, a leading manufacturer of specialty, high-quality in-vitro diagnostic and research assays, is pleased to announce the collaboration with Beckman Coulter for a worldwide distribution of the BÜHLMANN fCAL® turbo assay & BÜHLMANN fPELA® turbo assay... - September 26, 2024 - BUHLMANN Diagnostics Corp
AI's Role in Music Creation Sparks Debate: AEVUM Band's Album Showcases Harmony Between Technology and Art
The music industry is currently navigating a transformative yet contentious era, as artificial intelligence (A.I.) continues to redefine the boundaries of creativity. A recent article by TIME (1) highlights the polarized reactions to A.I.'s role in music creation, raising questions about authenticity, artistic integrity, and the future of human creativity. - September 17, 2024 - New Integrity Films
SEMA Lab Launches Crowdfunding Campaign for Ultrasound-Enhanced Meditation Retreat
The Science Enhanced Mindful Awareness (SEMA) Lab, co-directed by Dr. Jay Sanguinetti and world-renowned mindfulness teacher Shinzen Young, has officially launched a crowdfunding campaign to support their latest research endeavor: the world’s first ultrasound-enhanced meditation retreat. - September 13, 2024 - SEMA Lab
Krea Launches HOPE: An AI-Powered Synthetic Healthcare Panel for India
Krea, a Global Precision Health Insights Company, is unveiling HOPE (Hybrid Optimized Profiles and Engagement), an innovative solution designed to transform healthcare market research. In this first release, HOPE focuses on the patient segment. Healthcare research often struggles with limited... - September 10, 2024 - Krea
Pennington Biomedical’s Greaux Healthy Initiative Takes Aim at Childhood Obesity
Launch coincides with Childhood Obesity Awareness month; Campaign to share Pennington Biomedical research-sourced educational resources with physicians, educators, and families - September 08, 2024 - Pennington Biomedical Research Center
Pennington Biomedical's September Small Shift Focus is Hydration
This month, the Small Shifts Squad at Pennington Biomedical Research Center will focus on something simple yet incredibly impactful: hydrating more. Staying properly hydrated is essential for maintaining energy levels, improving concentration, and supporting overall health. This month, Small... - September 06, 2024 - Pennington Biomedical Research Center
Deliberate Coaching, Education Edition
A School Leader's Guide to Enhancing Teacher Effectiveness and Student Achievement Deliberate Coaching by Paul Gavoni and Nicholas L. Weatherly For decades, the U.S. education system’s focus when supporting teachers has been telling teachers what they should be doing and providing poor... - September 03, 2024 - ABA Technologies, Inc.
AEVUM Band's Heartfelt Ballad "Whenever I'm With You" Sparks Love and Intimacy
AEVUM Band USA, the celestial music act that blurs the boundaries of time and space, is releasing their latest music video, "Whenever I'm With You." This soul-stirring ballad invites listeners to rediscover the magic of love and intimacy. - August 27, 2024 - New Integrity Films
Pennington Biomedical Research Center Adds Director of Intellectual Property and Commercialization
Reis Alsberry Joins Pennington Biomedical Research Center to lead intellectural property and commercialization efforts. - August 23, 2024 - Pennington Biomedical Research Center
AEVUM Band Unveils Thought-Provoking Music Video "3 Billion Seconds" – A Captivating Exploration of Life's Choices
AEVUM Band USA, the boundary-pushing fusion of A.I. and human creativity, is thrilled to announce their latest music video, "3 Billion Seconds." This mesmerizing production delves into the essence of existence, urging viewers to contemplate the preciousness of time. Produced in collaboration with film-TV-music producer J.J. Barmettler, these unique music videos were created with A.I. imaging tools that transport viewers into a celestial realm where music transcends boundaries. - August 13, 2024 - New Integrity Films
Daily Ethics Book
A Behavior Analyst's Guide To Thinking About Ethics Differently Daily Ethics by Tyra P. Sellers, Emily A. Patrizi, and Sarah Lichtenberger While important to all professions, ethics is especially vital for those in the caring professions, like behavior analysts (BAs). While BAs receive required... - August 13, 2024 - ABA Technologies, Inc.
Pennington Biomedical Researcher Dr. Eric Ravussin Joined Experts from Around the World, Agreeing on Fasting Terminology to Boost Global Research
Scientists reach consensus for fasting terminology. - August 11, 2024 - Pennington Biomedical Research Center
Pennington Biomedical Scientists Outline Key Challenges and Promising Avenues in Obesity Genetics
Research article by Pennington Biomedical’s Dr. Sujoy Ghosh and Dr. Claude Bouchard included in the International Journal of Obesity - August 02, 2024 - Pennington Biomedical Research Center
CleverLMS Continues to Improve User Experience by Introducing Offline Mode for Taskhub
CleverLMS is excited to announce the latest enhancement to our platform: the Offline TaskHub feature. This new functionality allows users to continue their workflow seamlessly, even without an internet connection. Report data that employees wish to send is fully saved in a draft if the internet... - July 29, 2024 - CleverLMS
Busch Marine Inc. is Launching a Search Mission for the Wreck of SS I’m Alone
Busch Marine Inc., with locations in Plainwell, Freeland, and Carrollton Michigan, is embarking on a search mission for the wreck of the SS I’m Alone. This deep ocean search will be conducted in the Gulf of Mexico at a depth of 12,000 to 16,000 feet. The SS I’m Alone was a renowned... - July 24, 2024 - Busch Marine Inc.
U.S. Precision Medicine, Inc. Signs MOU to Deploy microNeb’s VIGIL Series Inhaler Technology to Enhance Absorption of Its New Drug Candidate in IND Process
U.S. Precision Medicine, Inc. (USPM) has signed a Memorandum of Understanding (MOU) to deploy microNeb's advanced inhaler technology to expedite the uptake of its new cancer drug candidate currently in the Investigational New Drug (IND) process. - July 16, 2024 - microNeb, Inc.
Pennington Biomedical’s Small Shift for July: Prioritizing Sleep
Small shifts can make a big impact on a person’s long-term health, and that includes catching some Z's. Quality sleep is essential for physical health, mental clarity and emotional resilience. This month, making a few small adjustments to sleep routines can enhance overall health and energy levels. - July 13, 2024 - Pennington Biomedical Research Center
AlbiMarketing Unveils Platform to Enhance Workplace Diversity in Remote Environments
New solution empowers remote teams, fostering a more inclusive work environment and driving organizational success in the digital age. - July 10, 2024 - Albi Marketing
Celebrate National Blueberry Month with Pennington Biomedical
The health benefits of blueberries are believed to be due to the diverse range of phytochemicals they contain, that act as antioxidants, anticancer agents, anti-neurodegenerative agents and anti-inflammatory agents. Because of these properties, many studies have been conducted to evaluate the health benefits of blueberries in chronic disease prevention. - July 10, 2024 - Pennington Biomedical Research Center
Immundiagnostik, Inc. Partners with BioPorto Diagnostics A/S to Expand Renal Research Offering
Immundiagnostik, Inc. has partnered with BioPorto Diagnostics A/S to expand its product portfolio to include BioPorto's line of NGAL ELISAs. - July 01, 2024 - Immundiagnostik, Inc.
The New Values-Based Safety Book
ABA Technologies Releases The New Values-Based Safety Book (3rd Edition) Every employee deserves to work for an organization that values their health and safety and ensures they return home at the end of each workday. Written by Terry McSween, PhD, and Adam Hockman, The New Values-Based Safety:... - June 27, 2024 - ABA Technologies, Inc.
Daicel Arbor Biosciences Launches New myTXTL® Kits to Accelerate Protein Expression
Daicel Arbor Biosciences is excited to announce the release of the next generation of its myTXTL® kits, for cell-free protein expression, designed to simplify and accelerate antibody discovery and protein engineering. These powerful new kits include the myTXTL Pro Kit and the myTXTL Antibody/DS... - June 27, 2024 - Daicel Arbor Biosciences
Cambridge Polymer Group Unveils Restructure to Accelerate Client Innovation through Material Science
Cambridge Polymer Group (CPG) announced a new leadership structure to better support clients in developing innovative products. CPG is creating a new five-person senior management team with deep materials science expertise, which will allow for closer collaboration with clients on complex projects. Dr. Gavin Braithwaite will be the new CEO and Dr. Stephen Spiegelberg will move to the new role of Chief Scientific Officer (CSO). - June 23, 2024 - Cambridge Polymer Group
Pennington Biomedical Shares Small Shifts for Nutritional Health
As a world-renowned nutrition research center, Pennington Biomedical has been on the forefront of how diet impacts health for decades. With hundreds of studies demonstrating the value of sound nutrition, the research center rolled out its Small Shifts campaign this year to showcase the cumulative value of daily common-sense changes. - June 23, 2024 - Pennington Biomedical Research Center
Simplifying Clinical Trials: TrialX Launches AI powered Clinical Trial Finder for Patient-Friendly Information
TrialX's new AI powered Clinical Trial Finder tool simplifies access to detailed information on over 58,000 active trials globally. The advanced AI technology transforms complex trial details into clear, concise language, making them understandable for a broader audience. Patients and caregivers can register as volunteers and receive notifications about suitable trials, enhancing participation in clinical research. - June 17, 2024 - TrialX
ABA Tech’s Driver Safety Science Recognized by Fleet Industry
ABA Technologies, Inc. (ABA Tech) has been featured by the Automotive Fleet Magazine for its behavior science-based contributions to the topic of corporate driver safety in the article: “Why Won't My Drivers Do What I Need Them to Do?” The well-being of employees behind the wheel is a... - June 14, 2024 - ABA Technologies, Inc.
AlbiMarketing Revolutionizes Employee Engagement with Innovative Digital Rewards Platform
New suite of customizable modules empowers companies to boost motivation, productivity, and retention through value-based recognition, team contests, skill development, and flexible benefits. - June 14, 2024 - Albi Marketing
Groundbreaking Study Shows Promise in AAV9 Gene Therapy for FOXG1 Syndrome; Rescue of Brain Structure Abnormalities and Deficits.
New publication shows groundbreaking result in FOXG1 AAV9 gene therapy studies, rescuing structural brain abnormalities caused by the pediatric rare disease, FOXG1 syndrome. This paper summarizing work done by the FOXG1 Research Center, led by Dr. Soo-Kyung Lee, Dr. Jae W. Lee and Dr. Kathrin Meyer (responsible for the SMA gene therapy), shows remarkable rescue of brain abnormalities using AAV9 gene therapy. - June 10, 2024 - FOXG1 Research Foundation
National Freshwater Foundation Granted 501(c)(3) Nonprofit Status by Internal Revenue Service
In a significant leap forward for freshwater conservation and sustainability, the National Freshwater Foundation is thrilled to announce its official IRS designation as a 501(c)(3) nonprofit organization. The IRS determined that the National Freshwater Foundation is a public charity under section 509(a)2. - June 10, 2024 - National Freshwater Foundation